COMMONWEALTH EQUITY SERVICES, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$3,809
-17.4%
100,921
-0.3%
0.01%
-11.1%
Q2 2023$4,612
+14.7%
101,221
+2.1%
0.01%
+12.5%
Q1 2023$4,020
+14.0%
99,118
+43.3%
0.01%0.0%
Q4 2022$3,525
-99.9%
69,175
-13.0%
0.01%
-27.3%
Q3 2022$4,283,000
-15.6%
79,535
+0.6%
0.01%
-15.4%
Q2 2022$5,077,000
-18.8%
79,049
-2.0%
0.01%
-7.1%
Q1 2022$6,252,000
-4.7%
80,633
+5.5%
0.01%
-6.7%
Q4 2021$6,560,000
+3.8%
76,428
-2.8%
0.02%
-6.2%
Q3 2021$6,322,000
-4.9%
78,607
-4.8%
0.02%
-5.9%
Q2 2021$6,649,000
-1.4%
82,600
+3.3%
0.02%
-10.5%
Q1 2021$6,745,000
+6.0%
79,982
+0.8%
0.02%0.0%
Q4 2020$6,364,000
+2.3%
79,321
+2.5%
0.02%
-9.5%
Q3 2020$6,223,000
-6.1%
77,393
+0.5%
0.02%
-16.0%
Q2 2020$6,629,000
+11.7%
76,995
+5.3%
0.02%
-10.7%
Q1 2020$5,937,000
-6.6%
73,134
-3.8%
0.03%
+16.7%
Q4 2019$6,358,000
+1.3%
76,038
+6.0%
0.02%
-11.1%
Q3 2019$6,276,000
+24.8%
71,759
+16.9%
0.03%
+22.7%
Q2 2019$5,028,000
+1.7%
61,400
+1.0%
0.02%
-4.3%
Q1 2019$4,945,000
+25.9%
60,818
+1.9%
0.02%
+9.5%
Q4 2018$3,928,000
-20.5%
59,691
-6.8%
0.02%
-12.5%
Q3 2018$4,938,000
+4.5%
64,058
+0.1%
0.02%
-4.0%
Q2 2018$4,727,000
+11.9%
64,011
-1.5%
0.02%
+8.7%
Q1 2018$4,224,000
-1.6%
64,957
-2.1%
0.02%0.0%
Q4 2017$4,291,00066,3800.02%
Other shareholders
BAXTER INTL INC shareholders Q1 2020
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders